Mechanisms of calpain proteolysis following traumatic brain injury: Implications for pathology and therapy: A review and update

被引:166
作者
Kampfl, A
Posmantur, RM
Zhao, X
Schmutzhard, E
Clifton, GL
Hayes, RL
机构
[1] UNIV TEXAS, HLTH SCI CTR, VIVIAN L SMITH CTR NEUROL RES, DEPT NEUROSURG, HOUSTON, TX 77030 USA
[2] WARNER LAMBERT PARKE DAVIS, PARKE DAVIS PHARMACEUT RES, ANN ARBOR, MI 48105 USA
[3] UNIV INNSBRUCK, DEPT NEUROL, A-6020 INNSBRUCK, AUSTRIA
关键词
calpain; calpain inhibition; cytoskeleton; cell death; traumatic brain injury;
D O I
10.1089/neu.1997.14.121
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Much recent research has focused on the pathological significance of calcium accumulation in the central nervous system (CNS) following cerebral ischemia, spinal cord injury (SCI), and traumatic brain injury (TBI). Disturbances in neuronal calcium homeostasis may result in the activation of several calcium-sensitive enzymes, including lipases, kinases, phosphatases, and proteases. One potential pathogenic event in a number of acute CNS insults, including TBI, is the activation of the calpains, calcium-activated intracellular proteases. This article reviews new evidence indicating that overactivation of calpains plays a major role in the neurodegenerative cascade following TBI in vivo. Further, this article presents an overview from in vivo and in vitro models of CNS injuries suggesting that administration of calpain inhibitors during the initial 24-h period following injury can attenuate injury-induced derangements of neuronal structure and function. Lastly, this review addresses the potential contribution of other proteases to neuronal damage following TBI.
引用
收藏
页码:121 / 134
页数:14
相关论文
共 137 条
  • [1] The ubiquitin-dependent proteolytic pathway in skeletal muscle: Its role in pathological states
    Argiles, JM
    LopezSoriano, FJ
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1996, 17 (06) : 223 - 226
  • [2] THE BREAKDOWN OF THE INDIVIDUAL NEUROFILAMENT PROTEINS BY CATHEPSIN-D
    BANAYSCHWARTZ, M
    DAHL, D
    HUI, KS
    LAJTHA, A
    [J]. NEUROCHEMICAL RESEARCH, 1987, 12 (04) : 361 - 367
  • [3] DEGRADATION OF CYTOSKELETAL PROTEINS IN EXPERIMENTAL SPINAL-CORD INJURY
    BANIK, NL
    HOGAN, EL
    POWERS, JM
    WHETSTINE, LJ
    [J]. NEUROCHEMICAL RESEARCH, 1982, 7 (12) : 1465 - 1475
  • [4] CALPAIN INHIBITOR AK295 PROTECTS NEURONS FROM FOCAL BRAIN ISCHEMIA - EFFECTS OF POSTOCCLUSION INTRAARTERIAL ADMINISTRATION
    BARTUS, RT
    HAYWARD, NJ
    ELLIOTT, PJ
    SAWYER, SD
    BAKER, KL
    DEAN, RL
    AKIYAMA, A
    STRAUB, JA
    HARBESON, SL
    LI, Z
    POWERS, J
    [J]. STROKE, 1994, 25 (11) : 2265 - 2270
  • [5] CALPAIN AS A NOVEL TARGET FOR TREATING ACUTE NEURODEGENERATIVE DISORDERS
    BARTUS, RT
    ELLIOTT, PJ
    HAYWARD, NJ
    DEAN, RL
    HARBESON, S
    STRAUB, JA
    LI, Z
    POWERS, JC
    [J]. NEUROLOGICAL RESEARCH, 1995, 17 (04) : 249 - 258
  • [6] TIME-RELATED NEURONAL CHANGES FOLLOWING MIDDLE CEREBRAL-ARTERY OCCLUSION - IMPLICATIONS FOR THERAPEUTIC INTERVENTION AND THE ROLE OF CALPAIN
    BARTUS, RT
    DEAN, RL
    CAVANAUGH, K
    EVELETH, D
    CARRIERO, DL
    LYNCH, G
    [J]. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1995, 15 (06) : 969 - 979
  • [7] DEGRADATION OF FODRIN AND MAP-2 AFTER NEONATAL CEREBRAL HYPOXIC-ISCHEMIA
    BLOMGREN, K
    MCRAE, A
    BONA, E
    SAIDO, TC
    KARLSSON, JO
    HAGBERG, H
    [J]. BRAIN RESEARCH, 1995, 684 (02) : 136 - 142
  • [8] DELAYED ANTAGONISM OF CALPAIN REDUCES EXCITOTOXICITY IN CULTURED NEURONS
    BRORSON, JR
    MARCUCCILLI, CJ
    MILLER, RJ
    [J]. STROKE, 1995, 26 (07) : 1259 - 1266
  • [9] MOLECULAR-CLONING OF THE INTERLEUKIN-1-BETA CONVERTING ENZYME
    CERRETTI, DP
    KOZLOSKY, CJ
    MOSLEY, B
    NELSON, N
    VANNESS, K
    GREENSTREET, TA
    MARCH, CJ
    KRONHEIM, SR
    DRUCK, T
    CANNIZZARO, LA
    HUEBNER, K
    BLACK, RA
    [J]. SCIENCE, 1992, 256 (5053) : 97 - 100
  • [10] CHAKRABARTI AK, 1996, IN PRESS REGULATION